Automated Imaging Reveals Where TAU Protein Originates in the Brain in Alzheimer's Disease (1 of 3) (IMAGE)
Caption
Four views of the origin of tauopathy in vivo. <i>Left</i>, TAU PET images for a cognitively normal person; <i>right: top</i>, 3D rendering of brain surface with TAU PET overlay; <i>bottom</i>, flat map showing topographic detail of surface anatomy with TAU origin identified in white outline. This material relates to a paper that appeared in the Jan. 20, 2021, issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by J.S. Sanchez at Massachusetts General Hospital in Boston, MA; and colleagues was titled, "The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography."
Credit
[Credit: Justin Sanchez and Keith Johnson, Massachusetts General Hospital]
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content